Back
Protara Therapeutics Vs. UniFirst Industry Stock Comparison
Buy
63
TARA
Protara Therapeutics
Last Price:
$5.93
Seasonality Move:
-6.78%
Buy
73
UNF
UniFirst
Last Price:
$214.87
Seasonality Move:
1.02%
Buy
63
Protara Therapeutics (TARA)
is a Buy
Is Protara Therapeutics a Buy, Sell or Hold?
-
The current Protara Therapeutics [TARA] share price is $5.91. The Score for TARA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
TARA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TARA Stock Price Chart
What is Protara Therapeutics's stock price today?
-
The Protara Therapeutics share price today is $5.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARA is experiencing slight buying pressure.
TARA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 62.82 | Buy |
Chaikin Money Flow: | 203622 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.71 - 6.33) | Buy |
Bollinger Bands (100): | (1.4 - 4.52) | Buy |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 72.95 | Buy |
Chaikin Money Flow: | 380542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (173.47 - 198.41) | Buy |
Bollinger Bands (100): | (180.75 - 197.95) | Buy |
TARA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.69 | Buy |
20-day SMA: | 5.65 | Buy |
50-day SMA: | 4.03 | Buy |
200-day SMA: | 2.85 | Buy |
8-day EMA: | 5.75 | Buy |
20-day EMA: | 5.38 | Buy |
50-day EMA: | 4.38 | Buy |
200-day EMA: | 3.07 | Buy |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.62 | Buy |
20-day SMA: | 183.05 | Buy |
50-day SMA: | 190.15 | Buy |
200-day SMA: | 178.74 | Buy |
8-day EMA: | 187.59 | Buy |
20-day EMA: | 185.11 | Buy |
50-day EMA: | 187.72 | Buy |
200-day EMA: | 182.46 | Buy |
Protara Therapeutics Earnings Growth & TARA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.09 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.98 per share, a decrease this year of $0.14 per share, and an increase next year of $0.92 per share.
Protara Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |